Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $55.23M. Across the group, the median move over the past trading day is +0.05%. Price change over the past year runs from −29.2% to +226.0% across the middle 80 percent of the group, with a median of +6.6%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| BIAF | bioAffinity Technologies, Inc. | $3.14M | Micro cap | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.